Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction

被引:145
|
作者
Kloner, RA
机构
[1] Hosp Good Samaritan, Inst Heart, Los Angeles, CA 90017 USA
[2] Univ So Calif, Keck Sch Med, Div Cardiovasc Med, Los Angeles, CA USA
关键词
D O I
10.1161/01.CIR.0000146906.42375.D3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:3149 / 3155
页数:7
相关论文
共 50 条
  • [1] COUPLE SATISFACTION TO THE TREATMENT OF ERECTILE DYSFUNCTION WITH PHOSPHODIESTERASE-5 INHIBITORS
    Jiann, Bang Ping
    Huang, S. T.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 105 - 106
  • [2] Phosphodiesterase-5 inhibitors for male erectile dysfunction
    Sui, ZH
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (09) : 1373 - 1388
  • [3] The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction
    Gupta, M
    Kovar, A
    Meibohm, B
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 987 - 1003
  • [4] Phosphodiesterase-5 inhibitors use in patients with erectile dysfunction and cardiovascular disease in clinical practice
    Mamedov, M. N.
    Sharvadze, G. G.
    Poddubsky, E. A.
    Ausheva, A. K.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2010, 6 (05) : 691 - 696
  • [5] Managing Erectile Dysfunction in Patients With Cardiovascular Diseases: The Efficacy and Safety of Phosphodiesterase-5 Inhibitors
    Cheng, Judy W. M.
    Berhane, Selamawit R.
    [J]. AMERICAN JOURNAL OF LIFESTYLE MEDICINE, 2009, 3 (03) : 201 - 211
  • [6] A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil
    Evans, Jeffery D.
    Hill, Stephen R.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 1159 - 1164
  • [7] A Review on Phosphodiesterase-5 Inhibitors as a Topical Therapy for Erectile Dysfunction
    Hamzehnejadi, Mohammadsadegh
    Tavakoli, Marziye Ranjbar
    Abiri, Ardavan
    Ghasempour, Ali
    Langarizadeh, Mohammad Amin
    Forootanfar, Hamid
    [J]. SEXUAL MEDICINE REVIEWS, 2022, 10 (03) : 376 - 391
  • [8] Drug Interactions With Phosphodiesterase-5 Inhibitors Used for the Treatment of Erectile Dysfunction or Pulmonary Hypertension
    Schwartz, Bryan G.
    Kloner, Robert A.
    [J]. CIRCULATION, 2010, 122 (01) : 88 - 95
  • [9] ASSESSING EXPERIENCE AND OUTCOMES WITH COMBINED USE OF PHOSPHODIESTERASE-5 INHIBITORS IN ERECTILE DYSFUNCTION TREATMENT
    McCarty, E.
    Hollow, K.
    Sadeghi-Nejad, H.
    Ashby, J.
    Goldmeier, D.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 317 - 317
  • [10] Role of Aortic Stiffness in Predicting Response to Phosphodiesterase-5 Inhibitors in the Treatment of Erectile Dysfunction
    Cicek, Omer Faruk
    Oncel, Halil Ferat
    Salar, Remzi
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2024, 121 (03)